Larvol Delta - Cognition-Therapeutics-Presents-Preclinical-Data-Identifying-Pathways-Impacted-by-Sigma2-Receptor-Modulators-in-Alzheimers-and-Parkinsons-Diseases

CT2168 - Cognition Therap

Elayta (CT1812) - Cognition Therap

https://www.globenewswire.com/news-release/2023/11/15/2780937/0/en/Cognition-Therapeutics-Presents-Preclinical-Data-Identifying-Pathways-Impacted-by-Sigma-2-Receptor-Modulators-in-Alzheimer-s-and-Parkinson-s-Diseases.html

Nov 15, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next